共 2 条
Radiation-associated circulatory disease mortality in a pooled analysis of 77,275 patients from the Massachusetts and Canadian tuberculosis fluoroscopy cohorts
被引:27
|作者:
Van Tran
[1
]
Zablotska, Lydia B.
[1
,2
]
Brenner, Alina V.
[1
]
Little, Mark P.
[1
]
机构:
[1] NCI, Radiat Epidemiol Branch, Bethesda, MD 20892 USA
[2] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA
来源:
基金:
美国国家卫生研究院;
关键词:
ISCHEMIC-HEART-DISEASE;
ATOMIC-BOMB SURVIVORS;
LONG-TERM SURVIVORS;
BREAST-CANCER;
CARDIOVASCULAR-DISEASES;
IONIZING-RADIATION;
CEREBROVASCULAR DISEASES;
LUNG-CANCER;
FOLLOW-UP;
MAYAK PA;
D O I:
10.1038/srep44147
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
High-dose ionising radiation is associated with circulatory disease. Risks associated with lower-dose (< 0.5 Gy) exposures remain unclear, with little information on risk modification by age at exposure, years since exposure or dose-rate. Tuberculosis patients in Canada and Massachusetts received multiple diagnostic x-ray fluoroscopic exposures, over a wide range of ages, many at doses < 0.5 Gy. We evaluated risks of circulatory-disease mortality associated with < 0.5 Gy radiation exposure in a pooled cohort of 63,707 patients in Canada and 13,568 patients in Massachusetts. Under 0.5 Gy there are increasing trends for all circulatory disease (n = 10,209; excess relative risk/Gy = 0.246; 95% CI 0.036, 0.469; p = 0.021) and for ischaemic heart disease (n = 6410; excess relative risk/Gy = 0.267; 95% CI 0.003, 0.552; p = 0.048). All circulatory-disease and ischaemic-heart-disease risk reduces with increasing time since exposure (p < 0.005). Over the entire dose range, there are negative mortality dose trends for all circulatory disease (p = 0.014) and ischaemic heart disease (p = 0.003), possibly due to competing causes of death over this dose interval. These results confirm and extend earlier findings and strengthen the evidence for circulatory-disease mortality radiation risk at doses < 0.5 Gy. The limited information on well-known lifestyle/medical risk factors for circulatory disease implies that confounding of the dose trend cannot be entirely excluded.
引用
收藏
页数:10
相关论文